Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
- PMID: 21145178
- PMCID: PMC3069146
- DOI: 10.1016/j.drugalcdep.2010.11.004
Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
Abstract
Background: This study aims to estimate general and racial-ethnic specific cumulative probability of developing dependence among nicotine, alcohol, cannabis or cocaine users, and to identify predictors of transition to substance dependence.
Methods: Analyses were done for the subsample of lifetime nicotine (n=15,918), alcohol (n=28,907), cannabis (n=7389) or cocaine (n=2259) users who participated in the first and second wave of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Discrete-time survival analyses were implemented to estimate the cumulative probability of transitioning from use to dependence and to identify predictors of transition to dependence.
Results: The cumulative probability estimate of transition to dependence was 67.5% for nicotine users, 22.7% for alcohol users, 20.9% for cocaine users, and 8.9% for cannabis users. Half of the cases of dependence on nicotine, alcohol, cannabis and cocaine were observed approximately 27, 13, 5 and 4 years after use onset, respectively. Significant racial-ethnic differences were observed in the probability of transition to dependence across the four substances. Several predictors of dependence were common across the four substances assessed.
Conclusions: Transition from use to dependence was highest for nicotine users, followed by cocaine, alcohol and cannabis users. Transition to cannabis or cocaine dependence occurred faster than transition to nicotine or alcohol dependence. The existence of common predictors of transition dependence across substances suggests that shared mechanisms are involved. The increased risk of transition to dependence among individuals from minorities or those with psychiatric or dependence comorbidity highlights the importance of promoting outreach and treatment of these populations.
Published by Elsevier Ireland Ltd.
Figures
Similar articles
-
Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Am J Drug Alcohol Abuse. 2013 May;39(3):168-79. doi: 10.3109/00952990.2013.772618. Am J Drug Alcohol Abuse. 2013. PMID: 23721532 Free PMC article.
-
Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.J Clin Psychiatry. 2016 Apr;77(4):e444-50. doi: 10.4088/JCP.14m09469. J Clin Psychiatry. 2016. PMID: 27137428
-
Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Addiction. 2011 Mar;106(3):657-69. doi: 10.1111/j.1360-0443.2010.03194.x. Epub 2010 Nov 16. Addiction. 2011. PMID: 21077975 Free PMC article.
-
The importance of considering polysubstance use: lessons from cocaine research.Drug Alcohol Depend. 2018 Nov 1;192:16-28. doi: 10.1016/j.drugalcdep.2018.07.025. Epub 2018 Sep 1. Drug Alcohol Depend. 2018. PMID: 30195242 Free PMC article. Review.
-
[Tobacco use and illicit substance use disorders: what should we have to do?].Presse Med. 2013 May;42(5):795-805. doi: 10.1016/j.lpm.2012.11.015. Epub 2013 Mar 23. Presse Med. 2013. PMID: 23528335 Review. French.
Cited by
-
Association Between Patient-Level Factors and Positive Treatment Response Among Individuals With a Psychostimulant Use Disorder: A Cross-Sectional Study.Subst Use. 2024 Oct 7;18:29768357241274483. doi: 10.1177/29768357241274483. eCollection 2024 Jan-Dec. Subst Use. 2024. PMID: 39420915 Free PMC article.
-
Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study.Mol Psychiatry. 2024 Sep 11. doi: 10.1038/s41380-024-02748-6. Online ahead of print. Mol Psychiatry. 2024. PMID: 39261672
-
Shared and unique 3D genomic features of substance use disorders across multiple cell types.medRxiv [Preprint]. 2024 Jul 19:2024.07.18.24310649. doi: 10.1101/2024.07.18.24310649. medRxiv. 2024. PMID: 39072016 Free PMC article. Preprint.
-
Pilot Implementation of Guiando Buenas Decisiones, an Evidence-Based Parenting Program for Spanish-Speaking Families, in Pediatric Primary Care in a Large, U.S. Health System: A Qualitative Interview Study.J Prev (2022). 2024 Jul 25. doi: 10.1007/s10935-024-00796-w. Online ahead of print. J Prev (2022). 2024. PMID: 39052125
-
The Development of Cannabinoids as Therapeutic Agents in the United States.Pharmacol Rev. 2024 Aug 15;76(5):915-955. doi: 10.1124/pharmrev.123.001121. Pharmacol Rev. 2024. PMID: 38849155 Review.
References
-
- Agrawal A, Neale MC, Prescott CA, Kendler KS. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behavior genetics. 2004;34:217–228. - PubMed
-
- Agrawal A, Pergadia ML, Saccone SF, Hinrichs AL, Lessov-Schlaggar CN, Saccone NL, Neuman RJ, Breslau N, Johnson E, Hatsukami D, Montgomery GW, Heath AC, Martin NG, Goate AM, Rice JP, Bierut LJ, Madden PA. Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. Addiction (Abingdon, England) 2008;103:1027–1038. - PubMed
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders : DSM-IV. American Psychiatric Association; Washington, DC: 1994.
-
- Anthony J, Warner L, Kessler R. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology. 1994;2:244–268.
Publication types
MeSH terms
Substances
Grants and funding
- MH076051/MH/NIMH NIH HHS/United States
- AA018111/AA/NIAAA NIH HHS/United States
- CA133050/CA/NCI NIH HHS/United States
- DA023200/DA/NIDA NIH HHS/United States
- Z01 AA000449-05/Intramural NIH HHS/United States
- MH082773/MH/NIMH NIH HHS/United States
- R01 DA019606/DA/NIDA NIH HHS/United States
- DA018652/DA/NIDA NIH HHS/United States
- DA019606/DA/NIDA NIH HHS/United States
- AA014223/AA/NIAAA NIH HHS/United States
- DA023973/DA/NIDA NIH HHS/United States
- K05 AA014223/AA/NIAAA NIH HHS/United States
- DA020783/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical